Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in TLRY — Tilray Brands, Inc.

CIK 1603466 STAMFORD, CT
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,911,791
+$1,563,769 QoQ
Shares Held
648,506
+746.7% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 235 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $450,936,643 across 22 Drug Manufacturers - Specialty & Generic names. TLRY ranks #13 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 201,159 $108,993,980
2 HLN
Haleon plc
 9,264,255 $86,435,499
3 LNTH
Lantheus Holdings, Inc.
 629,806 $69,870,677
4 INDV
Indivior Pharmaceuticals, Inc.
 1,250,639 $51,313,718
5 KNSA
Kiniksa Pharmaceuticals International, plc
 659,493 $42,174,577
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,059,778 $35,905,278
7 BHC
Bausch Health Companies Inc.
 2,235,821 $11,022,597
8 EOLS
Evolus, Inc.
 1,508,518 $10,469,114

All Filings in TLRY

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,911,791 648,506
2024-09-30 $1,348,022 765,922
2024-03-31 $4,407,188 1,784,287
2023-12-31 $5,433,223 2,362,271
2023-09-30 $4,162,354 1,741,571
2023-03-31 $523 207
2021-09-30 $1,243,029 110,100
2021-03-31 $1,652,471 72,700
2020-12-31 $5,714,268 691,800